Product image of Orgovyx (Relugolix) supplied by GNH India

Orgovyx

Active Ingredient:
Relugolix
Origin:
EU

Orgovyx (Relugolix)

Relugolix, the active ingredient in Orgovyx, is a selective GnRH antagonist presented as an oral tablet for oral use. It reduces circulating testosterone and is indicated for the treatment of advanced prostate cancer in men. The medication is formulated for once‑daily administration and is part of modern hormonal therapy strategies for oncology patients.

GNH India supplies Orgovyx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Orgovyx is a GnRH antagonist used in the management of advanced prostate cancer. It works by suppressing testosterone production, which fuels tumor growth.

  • Advanced prostate cancer: provides testosterone suppression to control disease progression.
  • Metastatic castration‑sensitive prostate cancer: used in combination with androgen‑deprivation therapy to improve overall survival.
  • Hormone‑sensitive prostate cancer: helps achieve rapid and sustained castration levels of testosterone.

How It Works

  • Relugolix competitively binds to gonadotropin‑releasing hormone (GnRH) receptors in the pituitary gland, blocking endogenous GnRH stimulation. This inhibition prevents the release of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), leading to a rapid decline in testosterone production from the testes, thereby reducing androgen‑driven tumor growth in prostate cancer.

Side Effects

Orgovyx may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Hot flashes: transient episodes of warmth and sweating.
  • Decreased libido: reduced sexual desire.
  • Fatigue: general feeling of tiredness.
  • Headache: mild to moderate head pain.
  • Nausea: occasional upset stomach.
  • Musculoskeletal pain: aches in muscles or joints.

Serious or Rare Side Effects

  • Cardiovascular events: myocardial infarction, stroke, or hypertension.
  • Liver enzyme elevations: increased ALT/AST levels.
  • Adrenal insufficiency: signs of cortisol deficiency.
  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Bone density loss: increased risk of fractures with prolonged use.

Precautions & Warnings

When prescribing Orgovyx, clinicians should consider several safety aspects.

  • Cardiovascular risk: assess history of heart disease before initiating therapy.
  • Liver function: monitor hepatic enzymes regularly during treatment.
  • Bone health: evaluate bone mineral density, especially in long‑term use.
  • Drug interactions: review concomitant medications that affect CYP3A4.
  • Pregnancy and breastfeeding: not indicated for women; avoid use during pregnancy.
  • Storage: Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Orgovyx may interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce relugolix exposure.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase relugolix levels and risk of toxicity.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (e.g., warfarin): monitor INR as hormonal changes can affect clotting.
  • Antihypertensives: blood pressure may fluctuate; adjust dosing as needed.
  • Other hormonal agents: concurrent use may alter endocrine balance.
  • Statins metabolized by CYP3A4: observe for increased statin concentrations.

Frequently Asked Questions

Orgovyx (relugolix) is prescribed to treat advanced prostate cancer in men. It works by lowering testosterone levels, which helps control tumor growth and disease progression.

Relugolix blocks gonadotropin‑releasing hormone (GnRH) receptors in the pituitary gland, preventing the release of luteinizing hormone and follicle‑stimulating hormone. This suppression leads to a rapid decline in testosterone production, reducing the androgen stimulation of prostate cancer cells.

The specific dose and regimen of Orgovyx are determined by the prescribing physician based on the patient’s clinical condition, disease stage, and other individual factors. Dosage instructions are provided on the prescription label.

Orgovyx is not indicated for use in women, and there is no data supporting its safety in pregnancy or lactation. It should be avoided by pregnant or breastfeeding individuals, and effective contraception is recommended for men of reproductive potential.

To request Orgovyx, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Orgovyx is a oral GnRH antagonist, offering rapid testosterone suppression without the initial surge seen with GnRH agonists. Compared with injectable hormonal agents, it provides convenient daily dosing and may have a different side‑effect profile, particularly regarding cardiovascular risk.

Store Orgovyx tablets at ambient temperature below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and keep out of reach of children.

Orgovyx is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with water; do not crush or split the tablet unless instructed.

Serious risks include cardiovascular events such as heart attack or stroke, significant liver enzyme elevations, adrenal insufficiency, and bone density loss with prolonged therapy. Patients should be monitored regularly for these conditions.

Orgovyx should not be used by individuals with known hypersensitivity to relugolix or any tablet components, patients with uncontrolled cardiovascular disease, severe liver impairment, or those taking contraindicated strong CYP3A4 inducers or inhibitors without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Relugolix

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT